Eurazeo PME is renowned for providing its portfolio companies with industrial expertise as well as financial and organizational resources that contribute to a sustainable development. Following international expansion and heavy investment in capital equipment early 2017, Eurazeo teamed up with In’Tech Medical, as it increases its capacity and offering to support expanding orthopedic reconstruction market. With operations in America, Europe, and Asia-Pacific, In’Tech Medical will rapidly benefit from Eurazeo PME’s business skills and international network.
“We are very pleased to partner with Eurazeo,” said Laurent Pruvost, CEO of In’Tech Medical. “Eurazeo has an excellent track-record as a committed shareholder. Their operational expertise makes them the ideal partner to help us implement our plans for organic expansion and through strategic acquisitions. With Eurazeo on board and thanks to our international team and our global footprint, we are positioned to serve the growing needs of our customers.”
“We are thrilled to welcome In’Tech Medical to the Eurazeo portfolio of companies,” commented Emmanuel Laillier, managing director of Eurazeo PME. “In’Tech Medical has been growing steadily in the past decade, building strong relationships and becoming one of the world leaders in the manufacturing of surgical instruments in orthopedics. We look forward to the opportunity of contributing to the success story.”
Founded in France in 2000, In’Tech Medical is an orthopedic contract manufacturer. With the company’s recent expansion in the United States and Malaysia, In’Tech Medical claims to be one of the world’s largest providers of orthopedic surgical instruments and implants. In’Tech Medical is also home to The Prototype Garage, prototype dedicated cells located both in Europe and the United States with the intent of serving industry with production-equivalent prototypes in a rapid-delivery setting.
Eurazeo PME is an investment firm and subsidiary of Eurazeo dedicated to majority investments in French small and medium-sized enterprises with a value of less than 200 million euros. Eurazeo PME acts as a long-term shareholder, providing its portfolio companies with all the financial, organizational, and human resources they need for a sustained transformation. With an investment horizon generally ranging from four to six years, the group guides its portfolio companies in creating sustained and, hence, responsible growth. This commitment is formalized and deployed through a corporate and social responsibility policy.
In 2016, Eurazeo PME generated 965 million euros in consolidated revenues and accompanied the development of 12 companies: Dessange International, Léon de Bruxelles, Péters Surgical, Colisée, Vignal Lighting Group, Groupe Flash, MK Direct, Orolia, AssurCopro, Smile and The Flexitallic Group and Fondis Bioritech as a minority shareholder.